The after effects of bird flu forces goose liver specialist, Delpeyrat, to change its strategy and priorities. That includes a new focus on salmon, writes newspaper, Le Figaro.
Managing director, Dominique Duprat, had revealed that the bird flue virus of recent years cast “permanent marks” on the foie gras segment. A corresponding fall in production alone cost Delpeyrat EUR 50 million, and the industry as whole, costs topped EUR 63 million, according to the newspaper.
![](https://cdn.innocode.digital/salmonbusiness/uploads/2018/01/Delpyrat-managing-director-Dominique-Duprat-231x380.jpg)
The company’s own turnover ended up at EUR 400 million in 2017, or down EUR 100 million year-on-year. To compensate for slumping core sales activity, Delpyrat has increased its focus on smoked salmon and its market share of 7.4 percent.
Alongside a focus on doubling international sales, the company has also fronted a larger assortment of premium brands.
“We’re trying to do less but in a better way,” Duprat was quoted as saying, adding that since 2013, Delpeyrat has invested in a number of salmon smokers.